Polymorphism of the apolipoprotein E and angiotensin I converting enzyme genes in Japanese patients with myocardial infarction

Coronary Artery Disease

Volumn 9, Issue 6, 1998, Pages 329-334

  Nakai, Kenji ^a   Fusazaki, Tetsuya ^a   Zhang, Tianqiao ^a   Shiroto, Takahiro ^a   Osawa, Masaki ^a   Kamata, Junya ^a   Itoh, Masahiro ^a   Nakai, Keiko ^a   Habano, Wataru ^a   Kiuchi, Takahiro ^b   Yamamori, Shunji ^c   Hiramori, Katsuhiko ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c LSI MEDIENCE CORPORATION   (Japan)

Author keywords

Angiotensin converting enzyme gene; Apolipoprotein E gene; Gene polymorphism; Myocardial infarction

Indexed keywords

APOLIPOPROTEIN E; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE DELETION; GENE INSERTION; GENOTYPE; HEART INFARCTION; HUMAN; HUMAN TISSUE; JAPAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; STENOSIS;

EID: 7844220232     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-199809060-00002     Document Type: Article

References (25)

1. Saito M, Fukami K, Hiramon K, Haze K, Sumiyoshi T, Kasagi H, et al. Long-term prognosis of patients with acute myocardial infarction: is mortality and morbidity as low as the incidence of ischemic heart disease in Japan? Am Heart J 1987; 113:891-897.
2. Simons LA. Interrelations of lipid and lipoproteins with coronary artery disease mortality in 19 countries. Am J Cardiol 1986; 57:5G-10G.
3. Williams RR, Hunt SC, Hopkins PH. Familial dyslipidemic hypertension. Evidence of 58 Utah families for syndrome present in approximately 12% of patients with essential hypertension. JAMA 1988; 259:3579-3584.
4. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Alveiler D, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359:641-647.
5. Nakai K, Itoh C, Miura Y, Hotta K, Musya T, Itoh T, et al. Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese. Circulation 1994; 90:2199-2202.
6. Utermann G, Hees M, Steinmetz A. Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinemia in man. Nature 1977; 269: 604-607.
7. Davignon J, Gregg RE, Sing CH. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988; 8:1-21.
8. Uterman G, Hardewig A, Zimmer F. Apolipoprotein E phenotypes in patients with myocardial infarction. Hum Genet 1984; 65:237-241.
9. Stengard JH, Zebra KE, Pekkanen J, Ehnholm C, Nissinen A, Sing CF. Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men. Circulation 1995; 91:265-269.
10. Tiret L, Kee F, Poirier O, Nicaud V, Lecerf L, Evans A, et al. Deletion polymorphism in angiotensin-converting enzyme genes associated with parental history of myocardial infarction. Lancet 1993; 341:991-992.
11. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ, Guddy T, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1992; 327:669-677.
12. Erdos E, Skidgel RA. The angiotensin I-converting enzyme. Lab Invest 1987; 56:345-348.
13. Ehlers MRW, Riodan JF. Angiotensin-converting enzyme: new concepts concerning its biological role. Biochemistry 1989; 28:5311-5318.
14. Fuster V, Ip JH, Badimon L, Badimon JJ, Stein B, Chesbro JH. Importance of experimental models for the development of clinical trials on thromboatherosclerosis. Circulation 1991; 83 (suppl):IV15-25.
15. Munro JM, Cotran RS. The pathogenesis of atherosclerosis: atherogenesis and inflammation. Lab Invest 1988; 58:249-261.
16. Scott J, Knott TJ, Shaw DJ, Brook JD. Localization of genes encoding apolipoproteins CI, CII, and E to the p13-cen region of human chromosome 19. Hum Genet 1985; 71:144-146.
17. Utterman G, Steinmetz A, Weber W. Genetic control of human apolipoprotein E polymorphism: comparison of one- and two dimensional techniques of isoprotein analysis. Hum Genet 1982; 60:344-351.
18. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J Lipid Res 1990; 31:545-548.
19. Asakawa J, Takahashi N, Rosenblum BB, Neel JV. Two dimensional gel studies of genetic variation in the plasma proteins of Amerindians and Japanese. Hum Genet 1985; 70:222-230.
20. Eto M, Watanabe, Ishii K. Reciprocal effects of apolipoprotein E alleles ε2 and ε4 on the plasma lipid levels in normolipidemic subjects. Clin Genet 1986; 29:477-484.
21. Ehnholm C, Lukka M, Kuusi T, Nikkila E, Utermann G. Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentration. J Lipid Res 1986; 27:227-235.
22. Cumming AM, Robertson F. Polymorphism at the apo E locus in relation to risk of coronary disease. Clin Genet 1984; 25:310-313.
23. Menzel H-J, Kladetzky R-G, Assmann G. Apolipoprotein E polymorphism and coronary artery disease. Arteriosclerosis 1983; 3:310-315.
24. van Bockxmeer FM, Mamotte CDS, Gibbon FA, Burke V, Taylor RR. Angiotensin-converting enzyme and apolipoprotein E genotypes and restenosis after coronary angioplasty Circulation 1995; 92:2066-2071.
25. Kamitani A, Rakugi H, Higaki J, Ohishi M, Shi S-J, Takami S, et al. Enhanced predictability of myocardial infarction in Japanese by combined genotype analysis. Hypertension 1995; 25:950-953.